Patents by Inventor Elif Arioglu Oral

Elif Arioglu Oral has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of LEPR Agonists for Pain
    Publication number: 20220098313
    Abstract: The present invention provides methods for reducing pain, the use of opioids and hospitalization in patients suffering with a leptin deficiency or leptin resistance condition such as lipodystrophy. There may be implications of this invention in other forms of chronic pain that involves centralization or hypersensitization of pain by the central nervous system.
    Type: Application
    Filed: September 15, 2021
    Publication date: March 31, 2022
    Inventors: Elif Arioglu Oral, Baris Akinci, Maria Cristina Foss de Freitas
  • Use of leptin to treat metabolic abnormalities associated with lipoatrophy
    Patent number: 8318666
    Abstract: Leptin, leptin analogs, and leptin derivatives are used to treat patients with lipoatrophy. Leptin is effective against conditions of lipoatrophy for both genetic and acquired forms of the disease. A therapeutically effective amount of leptin can be administered in a variety of ways, including subcutaneously and using gene therapy methods. Methods of the present invention contemplate administration of leptin, leptin analogs, and leptin derivatives to patients having a leptin level of approximately 4 ng/ml or less before treatment.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: November 27, 2012
    Assignees: Amgen, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Board of Regents, The University of Texas System
    Inventors: Alexander M. DePaoli, Elif Arioglu Oral, Simeon I. Taylor, Abhimanyu Garg